By David Colombo, Valerie Eng, and Sarath Ramakrishnan, KPMG
The industry has made unprecedented progress and addressed several challenges to ensure compliance with bio/pharma serialization and traceability requirements within each market. While these requirements contain further regulatory milestones on the horizon, manufacturers, distributors, pharmacies, and other parties in the supply chain must systematically adopt serialization in their normal business operations.
In Q2 2018, ISR asked 43 outsourcers of sterile injectable drug product manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources. Here's how respondents rated their organization’s experience and capacity with respect to outsourcing aseptic fill-finish.
Application Note |
By Ying Yang and Ma Sha,Eppendorf
In this application note, we explain the differences between batch, fed-batch, and continuous fermentation and how these influence culture growth. In our examples we studied E. coli fermentation at bench scale. The principles may also apply to bioprocesses using other microbes or mammalian cells, at both smaller and larger scales.
Building a bioprocessing facility is usually a complicated process and requires partnering with not only drug developers but also many different experts in various industries.
For more than 15 years, BioNetwork has been bringing together the right senior-level decision makers in pharma and biotech deal making. Our intimate setting allows you to nurture deal-making relationships and the right opportunities for your technology against the lush Dana Point backdrop. With plenty of time to network in a relaxed atmosphere, you are bound to carry your conversations from the meeting room, to sunset happy hour, and back to your office long after you leave the venue.